Average Co-Inventor Count = 11.34
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (22 from 329 patents)
2. Mirati Therapeutics, Inc. (5 from 38 patents)
3. Cogent Biosciences, Inc. (2 from 2 patents)
4. Bayer Aktiengesellschaft (1 from 12,157 patents)
25 patents:
1. 12351581 - Compounds for FGFR inhibition
2. 12281122 - PI3K inhibitors
3. 12187721 - Protein tyrosine phosphatase inhibitors
4. 11964989 - KRas G12D inhibitors
5. 11884664 - Protein tyrosine phosphatase inhibitors
6. 11634417 - Protein tyrosine phosphatase inhibitors
7. 11453683 - KRas G12D inhibitors
8. 10689377 - KRas G12C inhibitors
9. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
10. 10633381 - KRas G12C inhibitors
11. 10125134 - KRas G12C inhibitors
12. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
13. 9174981 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
14. 8865726 - Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
15. 8841455 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors